Alexion Pharmaceuticals

Listing Websites about Alexion Pharmaceuticals

Filter Type:

Acquisition of Alexion completed - AstraZeneca

(8 days ago) WebAstraZeneca today completed the acquisition of Alexion Pharmaceuticals, Inc. (Alexion). The closing of the acquisition marks the Company’s entry into medicines …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Alexion Pharmaceuticals - Wikipedia

(3 days ago) Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Its products include eculizumab (Soliris) and ravulizumab (Ultomiris), both used to treat the rare disorders of atypical hemolytic uremic syndrome (aHUS) and paro…

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Alexion, AstraZeneca Rare Disease, Completes Acquisition of …

(5 days ago) WebAlexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion …

Url: Visit Now

Category:  Drug Detail Drugs

Alexion Reports First Quarter 2021 Results - Alexion …

(3 days ago) WebBOSTON--(BUSINESS WIRE)--Apr. 30, 2021-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the first quarter of 2021. …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Alexion Pharmaceuticals, Inc. LinkedIn

(7 days ago) WebAlexion Pharmaceuticals, Inc. 283,006 followers on LinkedIn. Rare inspiration. Changing lives. Our mission is to transform …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Alexion Careers Job Search Results

(5 days ago) WebAstraZeneca completed its acquisition of Alexion, marking the creation of Alexion, AstraZeneca Rare Disease. If you’re interested in career opportunities with AstraZeneca, click here.. If you are a current Alexion …

Url: Visit Now

Category:  Drug Detail Drugs


(3 days ago) WebAlexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Alexion Pharmaceuticals Company Overview & News - Forbes

(7 days ago) WebAlexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Core Pharma About Us

(6 days ago) WebAs of January 2018, CorePharma was acquired by a group of industry investors with an unwavering commitment to remain a trusted, reliable and preferred partner of choice for …

Url: Visit Now

Category:  Drug Detail Drugs

Popular Searched

 › Eye doctors missoula medicaid

 › Melbourne regional medical center medical records

 › Northwest health laporte hospital address

 › Medical claim status codes

 › Basemental drugs mod sims 4 not working

 › Monster girl doctor streaming

 › Ihc select health plans

 › Lifestyle medicine valley medical center

 › Va hospitals in lexington ky

 › Cheshire hospital in keene nh

Recently Searched

 › Common drugs and their uses

 › Hospital fort worth texas

 › Mid south behavioral health

 › Memorialcare medical group org

 › Income limit for free medicare

 › Banner health clinic loveland

 › Online behavioral health courses

 › Nyu health clearance forms

 › How to file a medicare claim online

 › What do biomedical engineering do

FAQ about Alexion Pharmaceuticals

Where is Alexion Pharmaceuticals located?

Alexion Pharmaceuticals was founded in 1992 at Science Park in New Haven, Connecticut by Steven Squinto and Leonard Bell, a physician at Yale New Haven Hospital and assistant professor of medicine and pathology at Yale School of Medicine. In 2000, Alexion moved its headquarters from New Haven to Cheshire, Connecticut.

What can Alexion do for AstraZeneca?

We look forward to also applying Alexion’s complement-biology platform across areas of AstraZeneca’s broader early stage pipeline and, significantly, to the extraordinary opportunity to extend existing and future rare disease medicines to patients in many countries where AstraZeneca already has a strong presence.”

Is Alexion Pharmaceuticals stock a good buy?

Alexion Pharmaceuticals stock has received a consensus rating of hold. The average rating score is and is based on 0 buy ratings, 1 hold ratings, and 0 sell ratings. What was the 52-week low for Alexion Pharmaceuticals stock?

Why are patients so important to Alexion?

Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe.